Logo image of EPSN

EPSILON ENERGY LTD (EPSN) Stock Fundamental Analysis

NASDAQ:EPSN - Nasdaq - CA2943752097 - Common Stock - Currency: USD

6.6  -0.24 (-3.51%)

After market: 6.6 0 (0%)

Fundamental Rating

5

Taking everything into account, EPSN scores 5 out of 10 in our fundamental rating. EPSN was compared to 210 industry peers in the Oil, Gas & Consumable Fuels industry. EPSN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. EPSN has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

EPSN had positive earnings in the past year.
EPSN had a positive operating cash flow in the past year.
In the past 5 years EPSN has always been profitable.
EPSN had a positive operating cash flow in each of the past 5 years.
EPSN Yearly Net Income VS EBIT VS OCF VS FCFEPSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

EPSN has a Return On Assets (3.54%) which is comparable to the rest of the industry.
EPSN has a Return On Equity of 4.45%. This is comparable to the rest of the industry: EPSN outperforms 43.81% of its industry peers.
The Return On Invested Capital of EPSN (5.62%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for EPSN is significantly below the industry average of 23.80%.
The 3 year average ROIC (10.21%) for EPSN is well above the current ROIC(5.62%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 3.54%
ROE 4.45%
ROIC 5.62%
ROA(3y)11.91%
ROA(5y)9.69%
ROE(3y)14.27%
ROE(5y)11.75%
ROIC(3y)10.21%
ROIC(5y)8.94%
EPSN Yearly ROA, ROE, ROICEPSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

EPSN's Profit Margin of 11.18% is in line compared to the rest of the industry. EPSN outperforms 59.52% of its industry peers.
EPSN's Profit Margin has declined in the last couple of years.
The Operating Margin of EPSN (26.81%) is better than 61.90% of its industry peers.
EPSN's Operating Margin has declined in the last couple of years.
EPSN has a Gross Margin of 73.51%. This is amongst the best in the industry. EPSN outperforms 85.24% of its industry peers.
EPSN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.81%
PM (TTM) 11.18%
GM 73.51%
OM growth 3Y-31.37%
OM growth 5Y-9.53%
PM growth 3Y-39.36%
PM growth 5Y-28.44%
GM growth 3Y-4.33%
GM growth 5Y-0.17%
EPSN Yearly Profit, Operating, Gross MarginsEPSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EPSN is creating some value.
Compared to 1 year ago, EPSN has less shares outstanding
The number of shares outstanding for EPSN has been reduced compared to 5 years ago.
There is no outstanding debt for EPSN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EPSN Yearly Shares OutstandingEPSN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
EPSN Yearly Total Debt VS Total AssetsEPSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 3.72 indicates that EPSN is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.72, EPSN belongs to the top of the industry, outperforming 87.14% of the companies in the same industry.
There is no outstanding debt for EPSN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.72
ROIC/WACC0.6
WACC9.37%
EPSN Yearly LT Debt VS Equity VS FCFEPSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 1.66 indicates that EPSN should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.66, EPSN is doing good in the industry, outperforming 72.38% of the companies in the same industry.
A Quick Ratio of 1.66 indicates that EPSN should not have too much problems paying its short term obligations.
EPSN's Quick ratio of 1.66 is fine compared to the rest of the industry. EPSN outperforms 75.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1.66
EPSN Yearly Current Assets VS Current LiabilitesEPSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

3

3. Growth

3.1 Past

EPSN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.39%, which is quite good.
EPSN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -22.77% yearly.
The Revenue has grown by 35.22% in the past year. This is a very strong growth!
The Revenue has been growing slightly by 3.38% on average over the past years.
EPS 1Y (TTM)17.39%
EPS 3Y-43.6%
EPS 5Y-22.77%
EPS Q2Q%157.14%
Revenue 1Y (TTM)35.22%
Revenue growth 3Y-9.41%
Revenue growth 5Y3.38%
Sales Q2Q%102.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y206%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year38.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPSN Yearly Revenue VS EstimatesEPSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
EPSN Yearly EPS VS EstimatesEPSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2020 2023 2024 2025 0 0.1 0.2 0.3 0.4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 24.44, EPSN is valued on the expensive side.
EPSN's Price/Earnings ratio is in line with the industry average.
EPSN is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.50, which is the current average of the S&P500 Index.
EPSN is valuated correctly with a Price/Forward Earnings ratio of 13.48.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EPSN is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.44, EPSN is valued rather cheaply.
Industry RankSector Rank
PE 24.44
Fwd PE 13.48
EPSN Price Earnings VS Forward Price EarningsEPSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EPSN indicates a somewhat cheap valuation: EPSN is cheaper than 63.81% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.56
EPSN Per share dataEPSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

EPSN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.12
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.52%, EPSN has a reasonable but not impressive dividend return.
EPSN's Dividend Yield is comparable with the industry average which is at 6.41.
Compared to an average S&P500 Dividend Yield of 2.35, EPSN pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.52%

5.2 History

EPSN has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
EPSN Yearly Dividends per shareEPSN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

123.78% of the earnings are spent on dividend by EPSN. This is not a sustainable payout ratio.
DP123.78%
EPS Next 2YN/A
EPS Next 3YN/A
EPSN Yearly Income VS Free CF VS DividendEPSN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M
EPSN Dividend Payout.EPSN Dividend Payout, showing the Payout Ratio.EPSN Dividend Payout.PayoutRetained Earnings

More info and screens

EPSILON ENERGY LTD

NASDAQ:EPSN (7/18/2025, 8:00:01 PM)

After market: 6.6 0 (0%)

6.6

-0.24 (-3.51%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-07 2025-08-07
Inst Owners62.4%
Inst Owner Change0%
Ins Owners4.6%
Ins Owner Change2.75%
Market Cap145.33M
Analysts82.86
Price Target8.57 (29.85%)
Short Float %2.27%
Short Ratio2.06
Dividend
Industry RankSector Rank
Dividend Yield 3.52%
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP123.78%
Div Incr Years0
Div Non Decr Years2
Ex-Date06-13 2025-06-13 (0.0625)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.56%
Min EPS beat(2)-41.18%
Max EPS beat(2)26.05%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)16.19%
Min Revenue beat(2)-2.91%
Max Revenue beat(2)35.29%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)9.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 24.44
Fwd PE 13.48
P/S 3.66
P/FCF N/A
P/OCF 6.69
P/B 1.46
P/tB 1.46
EV/EBITDA 6.56
EPS(TTM)0.27
EY4.09%
EPS(NY)0.49
Fwd EY7.42%
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)0.99
OCFY14.95%
SpS1.8
BVpS4.53
TBVpS4.53
PEG (NY)0.12
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.54%
ROE 4.45%
ROCE 9.16%
ROIC 5.62%
ROICexc 5.97%
ROICexgc 5.97%
OM 26.81%
PM (TTM) 11.18%
GM 73.51%
FCFM N/A
ROA(3y)11.91%
ROA(5y)9.69%
ROE(3y)14.27%
ROE(5y)11.75%
ROIC(3y)10.21%
ROIC(5y)8.94%
ROICexc(3y)15.79%
ROICexc(5y)13.41%
ROICexgc(3y)15.79%
ROICexgc(5y)13.41%
ROCE(3y)16.64%
ROCE(5y)14.58%
ROICexcg growth 3Y-47.2%
ROICexcg growth 5Y-12.62%
ROICexc growth 3Y-47.2%
ROICexc growth 5Y-12.62%
OM growth 3Y-31.37%
OM growth 5Y-9.53%
PM growth 3Y-39.36%
PM growth 5Y-28.44%
GM growth 3Y-4.33%
GM growth 5Y-0.17%
F-Score7
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 212.4%
Cap/Sales 60.35%
Interest Coverage 608.25
Cash Conversion 99.07%
Profit Quality N/A
Current Ratio 1.66
Quick Ratio 1.66
Altman-Z 3.72
F-Score7
WACC9.37%
ROIC/WACC0.6
Cap/Depr(3y)242.3%
Cap/Depr(5y)173.79%
Cap/Sales(3y)62.73%
Cap/Sales(5y)45.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.39%
EPS 3Y-43.6%
EPS 5Y-22.77%
EPS Q2Q%157.14%
EPS Next Y206%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)35.22%
Revenue growth 3Y-9.41%
Revenue growth 5Y3.38%
Sales Q2Q%102.29%
Revenue Next Year38.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y114.8%
EBIT growth 3Y-37.82%
EBIT growth 5Y-6.47%
EBIT Next Year537.1%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-107.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-42.67%
OCF growth 3Y-5.61%
OCF growth 5Y5.32%